SBIR-STTR Award

Self-regulating pump chamber for standard roller pump
Award last edited on: 2/22/2019

Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$46,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
George D Repetti

Company Information

Adam Spence (AKA: Spectrum Plastics Company~Adam Spence Vascular~Adam Spence Corporation~Fermatex Vascular Technologies)

1746 New Jersey Route 34
Wall, NJ 07719
   (732) 681-7070
   marketing@adamspence.com
   www.adamspence.com
Location: Single
Congr. District: 04
County: Monmouth

Phase I

Contract Number: N/A
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1987
Phase I Amount
$46,000
The roller pump, used to pump blood flow during cardiopulmonary bypass and to provide long-term circulatory support, is a constant blood-flow device. It maintains constant flow independently of the clinically expected changes in inlet pressures. A decrease in blood supply to the inlet of the pump without a concomitant decrease in pump speed can cause excessive suction leading to air embolism, thrombosis, and damage by the "venous" cannula to the vessel's intima or, with a bubble oxygenator, the emptying of the oxygenator, pumping air to the patient. The purpose of this research is to design, fabricate, and evaluate a new, innovative disposable pump chamber for the standard roller pump that self-controls the pump flow as a function of inlet or filling pressure, much like the natural heart. The pump chamber consists of an easily collapsible thin-wall tubing (TWT) housed and sealed in a standard pump tubing. The inner TWT serves to pump blood and the outer tubing serves as a mechanical support and controlled pressure environment for the TWT. This pump chamber can provide additional safety during open heart surgery and also function as an inexpensive, self-controlling mechanism for long term circulatory support. National Heart, Lung, and Blood Institute (NHLBI)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----